NCM
ZLAB icon

NEXTBio Capital Management’s Zai Lab ZLAB Stock Holding History

NEXTBio Capital Management’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48M Hold
183,362
– – 1.6% 18
2026
Q1 		$3.45M Buy
183,362
+20,000
+12% +$371K 1.6% 20
2025
Q4 		$2.88M Buy
+163,362
New +$3.82M 1.69% 21

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

NEXTBio Capital Management's ZLAB Position: Q2 2026 in Review

NEXTBio Capital Management held its Zai Lab (ZLAB) position steady in Q2 2026 at 183,362 shares worth $3.48M. The position accounts for 1.6% of the portfolio, ranked #18.

NEXTBio Capital Management first reported a position in ZLAB in Q4 2025 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • NEXTBio Capital Management held 183,362 shares of Zai Lab worth $3.48M as of Q2 2026.
  • NEXTBio Capital Management left its Zai Lab share count unchanged in Q2 2026.
  • Zai Lab made up 1.6% of NEXTBio Capital Management's portfolio in Q2 2026, its #18 holding.
  • NEXTBio Capital Management first reported a position in Zai Lab in Q4 2025 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on NEXTBio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.